Etiology of Noise-Induced Hearing Loss (NIHL) and its Symptomatic Correlation with Audiometry Observations in Type II Diabetes

  • Meena K. Yadav
  • K. S. Yadav
Original Article


Type II diabetic mellitus (DM) is a chronic metabolic disease that impairs normal insulin production and glucose transport to the liver and muscles. In the India, about 1–5% population suffer from diabetes or related complication. So there is need to cure this disease. DM chronic auditory complications may include spiral ganglia atrophy, degeneration of the vestibulocochlear nerve myelin sheath, reduction of the number of spiral lamina nerve fibres, and thickening of the capillary walls of the stria vascularis and small arteries. This study aims to know the incidence of common parameters, blood sugar levels, levels of lipids and the hearing thresholds of individuals. It is a Noise-Induced Hearing Loss research study featuring hearing impairment in transport workers diagnosed as type II diabetic. All individuals were interviewed by various questioners related to listening ability of subjects and underwent a physical examination, blood investigations and audiometry. Hearing impairment was more prevalent among adults with diabetes. Sensory neuron hearing loss is predominant in both study groups. Mixed Bilateral Hearing Loss showed significant p value in (>.001) by audiometry. The percentage of hearing loss in diabetes (ranges 5.3–28.1%) and in non-diabetics (ranges 3.4–24.1%) and risk factors in diabetes (ranges 22.8–35.1%) over nondiabetics (ranges 17.2–20.1%) which is eye opener. The correlation between type II diabetes and hearing impairment was independent of known risk factors for hearing impairment, such as noise exposure, build-up wax, ototoxic medication, smoking, tobacco chewing etc.


Type II diabetic mellitus Noise induced hearing loss Audiometric analysis 



We would like to express our sincere thanks to medical administrators, faculties and paramedical staff of D. Y. Patil University, Navi Mumbai. We wish thanks to Dr Sakharam Muley for statistical analysis. Special thanks to the subjects who have participated in this research work, without their participation, this project would not have been possible.

Author’s Contribution

Yadav Meena K, analytical work, data entry, IEC presentation and manuscript writing. Yadav KS, topic guidance, study design, protocol design and supervision of work.

Compliance with Ethical Standards

Ethical Approval

All authors are here by declared that all experiments have been examined and approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

Informed Consent

All authors declare that ‘written informed consent was obtained from patients for publication of outcome of this study’ copy of written consent may retrieve from us, if required.


  1. 1.
    Muhlestein JB, Anderson JL, Horne BD, Lavasani F, Allen-Maycock CA, Bair TL, Pearson RR, Carlquist JF (2003) Effect of fasting glucose levels on mortality rate in subjects with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J146:351–358CrossRefGoogle Scholar
  2. 2.
    Thrainsdottir IS, Aspelund T, Thorgeirsson G, Gudnason V, Hardarson T, Malmberg K, Sigurdsson G, Rydén L (2005) The association between glucose abnormalities and heart failure in the population-based Reykjavík study. Diabetes Care 28:612–616CrossRefPubMedGoogle Scholar
  3. 3.
    Nielson C, Lange T (2005) Blood glucose and heart failure in nondiabetic subjects. Diabetes Care 28:607–611CrossRefPubMedGoogle Scholar
  4. 4.
    The DECODE Study Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 354:617–621CrossRefGoogle Scholar
  5. 5.
    Penido NO, Ramos HVL, Barros FA, Cruz OLM, Toledo RN (2006) Fatoresclínicos, etiológicos e evolutivos da audiçãonasurdezsúbita. Braz J Otorhinolaryngol. 71(5):633–638CrossRefGoogle Scholar
  6. 6.
    Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111:3481–3488CrossRefPubMedGoogle Scholar
  7. 7.
    Fagot-Campagna A, Rolka DB, Beckles GL, Gregg EW, Narayan KM (2000) Prevalence of lipid ablormalities, awareness, and treatment in US adults with diabetes. Diabetes 49(Suppl. 1):A78Google Scholar
  8. 8.
    Rosenson RS (2004) Clinical role of LDL and HDL subclasses and apolipoprotein measurement. ACC Curr J Rev 13:33–37CrossRefGoogle Scholar
  9. 9.
    Alvarenga KF, Duarte JL, Silva DPC, Agostinho-Pesse RS, Negrato CA, Costa OA (2005) P300 cognitive potential in subjects with type II diabetic group subjects mellitus. Braz J Otorhinolaryngol 71(2):202–207CrossRefGoogle Scholar
  10. 10.
    Maia CAS, Campos CAH (2005) Type II diabetic group subjects Mellitus as an etiological factor of hearing impairment. Braz J Otorhinolaryngol 71(2):208–214CrossRefPubMedGoogle Scholar
  11. 11.
    Robbins SL, Cotran RS, Kumar V (1991) Pathologic basis of disease, 3rd edn. WB Sauders Co, PhiladelphiaGoogle Scholar
  12. 12.
    Makishima K, Tanaka AK (1971) Pathological changes of the inner ear and central auditory pathway in type II diabetic group subjects. Ann Otolrhinollaryngol 80(2):218–228Google Scholar
  13. 13.
    Malucelli DA, Malucelli FJ, Fonseca VR, Zeigeboim B, Ribas A, Trotta FD, da Silva TP (2012) Hearing impairment prevalence in subjects with type II diabetic group subjects mellitus type I. Braz J Otorhinolaryngol 78(3):105–115CrossRefPubMedGoogle Scholar
  14. 14.
    Ferreira CA Jr, Guimarães RES, Becker HMG, Silva CDL, Gonçalves TML, Crosara PFTB et al (2000) Avaliaçãometabólica do paciente com labirintopatia. Arq Otorrinolaringol 4(1):28–32Google Scholar
  15. 15.
    Marchiori LMM, Gibrin PCD (2003) Type II diabetic group subject’s mellitus: prevalência de alteraçõesauditivas. Arq Bras Endocrinol Metab 47(1):82–86CrossRefGoogle Scholar
  16. 16.
    Franks JR, Stephenson MR, Merry CJ (1996) Preventing occupational hearing loss: a practical guide. Centers for Disease Control and Prevention National Institute for Occupational Safety and Health. DHHS (NIOSH) Publication No. 96-110Google Scholar
  17. 17.
    World Health Organization (1999) Definition, diagnosis & classification of diabetes mellitusand its complications. Part 1: diagnosis & classification of diabetes mellitus WHO/NCD/NCS 99.2. World Health Organization, GenevaGoogle Scholar
  18. 18.
    Nathan DM, Turgeon H, Regan S (2007) Relationship between glycatedhaemoglobin levelsand mean glucose levels over time. Diabetologia 50:2239–2244CrossRefPubMedGoogle Scholar
  19. 19.
    International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327–1334CrossRefGoogle Scholar
  20. 20.
    Austin Donald F, Konrad-Martin Dawn, Griest Susan, McMillan Garnett P, McDermott Daniel, Fausti Stephen (2009) Diabetes-related changes in hearing. Laryngoscope 119:1788–1796CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Panchu P (2008) Auditory acuity in type 2 diabetes mellitus. Int J Diabetes Dev Ctries 28(4):114–120CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kakarlapudi V, Sawyer R, Staecker H (2003) The effect of diabetes on sensorineural hearing loss. Otol Neurotol 24:382–386CrossRefPubMedGoogle Scholar
  23. 23.
    Dalton SD, Cruickshanks KJ, Klein R, Klein BE, Wiley TL (1998) Association of NIDDM and hearing loss. Diabetes Care 21:1540–1544CrossRefPubMedGoogle Scholar
  24. 24.
    Yadav M, Yadav KS, Netterwala A, Khan B, Desai NS (2015) Noise-Induced Hearing Loss (Nihl) andit’s Correlation with audiometric observations in heavy vehicle operators suffering with metabolic disorders. Int J Med Clin Res 6(1):315–320Google Scholar
  25. 25.
    Taylor IG, Irwin J (1978) Some audiological aspects of diabetes mellitus. J Laryngol Otol 92:99–113CrossRefPubMedGoogle Scholar
  26. 26.
    Axelson A, Fagerberg SE (1968) Auditory functions in diabetics. Acta Otolaryngol 66:49–63CrossRefGoogle Scholar
  27. 27.
    Hsin-Chieh Y, Bruce D, Schmidt MA et al (2010) Smoking, smoking cessation and risk for type 2 diabetes mellitus. Ann Intern Med 152(1):10–17CrossRefGoogle Scholar

Copyright information

© Association of Otolaryngologists of India 2017

Authors and Affiliations

  1. 1.School of AyurvedaD Y Patil UniversityNavi MumbaiIndia
  2. 2.School of MedicineD Y Patil UniversityNavi MumbaiIndia

Personalised recommendations